Wilfredo Cosme-blanco, MD,PHD in Aguadilla, PR - Medicare Allergy/immunology

Wilfredo Cosme-blanco, MD,PHD is a medicare enrolled "Allergy & Immunology" physician in Aguadilla, Puerto Rico. He graduated from medical school in 2018 and has 6 years of diverse experience with area of expertise as Allergy/immunology. His current practice location is 47 Ave Severiano Cuevas Ste 1, Aguadilla, Puerto Rico. You can reach out to his office (for appointments etc.) via phone at (787) 658-6133.

Wilfredo Cosme-blanco is licensed to practice in Puerto Rico (license number 19335) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1285977793.

Contact Information

	Wilfredo Cosme-blanco, MD,PHD
	47 Ave Severiano Cuevas Ste 1, Aguadilla, PR 00603-5751
	(787) 658-6133
	Not Available

Physician's Profile

Full Name	Wilfredo Cosme-blanco
Gender	Male
Speciality	Allergy/immunology
Experience	6 Years
Location	47 Ave Severiano Cuevas Ste 1, Aguadilla, Puerto Rico
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Wilfredo Cosme-blanco graduated from medical school in 2018

NPI Data:

NPI Number: 1285977793
Provider Enumeration Date: 04/03/2013
Last Update Date: 11/17/2023

Medicare PECOS Information:

PECOS PAC ID: 7012251473
Enrollment ID: I20181212000711

Medical Identifiers

Medical identifiers for Wilfredo Cosme-blanco such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1285977793	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
208000000X	Pediatrics	19335 (Puerto Rico)	Secondary
207K00000X	Allergy & Immunology	19335 (Puerto Rico)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Wilfredo Cosme-blanco is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Wilfredo Cosme-blanco, MD,PHD Po Box 4864, Aguadilla, PR 00605-4864 Ph: (787) 658-6133	Wilfredo Cosme-blanco, MD,PHD 47 Ave Severiano Cuevas Ste 1, Aguadilla, PR 00603-5751 Ph: (787) 658-6133

News Archive

Multimodal approach relieves obstetric back and pelvic pain

Pregnant women with low-back pain and pelvic pain could benefit from a multimodal approach of musculoskeletal and obstetric management, say researchers.

State roundup: 'Green Houses' in Calif.; 'Accredtive Secret Sauce' gets scrutiny in Minn.

A new idea elbowed its way into the familiar pile of health care legislation in the Senate Committee on Health yesterday. A nursing home model - the "Green House Project" - bucks the cold, institutional feel of many long-term care facilities. ... The idea is to have a small facility laid out like a regular home, with living areas such as a dining room and kitchen, as well as a private room and bathroom for each patient.

ADHD linked to poorer eating habits: Study

A new study by researchers in Perth has linked attention-deficit hyperactivity disorder with "western-style" diets in teenage sufferers. For the study the Telethon Institute for Child Health and Research examined the diets of 1,800 adolescents, categorizing them as either eating a healthy mix of fruit, vegetables, whole grains and fish or the "western-style" highly-processed, fried and take-away foods. The latter contained more food additives, flavors or colors, which could lead to hyperactivity or changes to chemicals that control parts of the brain dealing with attention and concentration say researchers.

Researchers discover promising new approach for leukemia treatment

A group of researchers at the Institute for Research in Immunology and Cancer of Universit- de Montr-al discovered a promising new approach to treating leukemia by disarming a gene that is responsible for tumor progression. That gene, known as Brg1 is a key regulator of leukemia stem cells that are the root cause of the disease, resistance to treatment and relapse.

Aprotinin use associated with an increased risk of death following CABG surgery

Aprotinin, a drug used for limiting blood loss in patients undergoing cardiac surgery, is associated with an increased risk of death during five years following the surgery, according to a new study in the February 7 issue of JAMA: The Journal of the American Medical Association.

Wilfredo Cosme-blanco, MD,PHD - Medicare Allergy/immunology in Aguadilla, PR